Book Name: Frontiers in Anti-infective Agents
Frontiers in Anti-Infective Agents Volume 5 is a collection of notable research efforts, successful anti-infective drug development programmes and a comprehensive overview of the successes and failures of recent clinical trials in this domain. The volume covers interesting topics: 1) the treatment of acute wounds with the vikut® formula, 2) anti-infective treatment of ocular diseases and 3) sars-cov vaccine development and antimicrobial therapy for SARS symptoms. A chapter summarizing recent anti-infective approaches rounds up the contents of this volume.
This volume is a timely reference for postgraduate scholars and researchers seeking updates in specific areas of anti-infective drug development. Allied healthcare professionals (clinical and public healthcare professionals) can also benefit from the information presented within.
Audience:Postgraduate scholars, researchers studying anti-infective drug developments; Allied healthcare professionals involved in the administration of anti-infective agents.
About the Editors:
Dr. Parvesh Singh is an NRF-rated researcher in the School of Chemistry and Physics (SCP) at the University of KwaZulu-Natal (UKZN), Durban (South Africa). After completing his Ph.D. degree (Organic Chemistry), in 2006, from the Guru Nanak Dev University (India), Dr. Singh joined a pharmaceutical company (Jubilant Organosys) as a Research Scientist and then moved to South Africa to pursue his Post-doctoral studies at the Durban University of Technology. In 2014, Dr. Singh was appointed as a Senior Lecturer at UKZN and then promoted to Associate Professor in the same institution. Dr. Singh’s research primarily focuses on the synthesis of heterocyclic scaffolds and their biological testing and molecular modelling studies. Dr. Singh is a recipient of a prestigious DST-NRF Free-standing fellowship and has been featured as one of the emerging researchers in South Africa by the National Research Foundation (NRF). He has also been a recipient of top University and College research awards on several occasions. He has co-authored more than 100 research papers in top tier international journals and serving as an editorial board member and ambassador for several reputed publishers.
Dr. Vipan Kumar Ph.D. has been working as an Assistant Professor in the Department of Chemistry, Guru Nanak Dev University, Amritsar, since 2009. He obtained his Ph.D. with Prof. Mohinder P Mahajan in the Department of Applied Chemistry, GNDU. In 2007, he moved to the University of Cape Town (UCT), South Africa, to pursue his post-doctoral studies with Prof. Kelly Chibale. In 2015, he was awarded a research fellowship from Carl Tryggers research foundation, Sweden to carry out research at University of Umea, Sweden. His research interests include the development of diverse synthetic protocols for the synthesis of novel molecular frameworks targeting tropical infections. He has also been engaged in the utilization of b-lactam synthon protocols for the synthesis of functionally decorated and biologically relevant heterocycles with medicinal potential.
Prof. Rajshekhar Karpoormath graduated with his Ph.D. (2013) from the School of Chemistry and Physics, University of KwaZulu-Natal (UKZN), Durban, South Africa. He is currently an Associate Professor and Academic Leader of Research in the College of Health Sciences, UKZN. He is also a nationally recognized rated researcher by National Research Foundation-South Africa (NRF-SA). Prof Karpoormath started his independent research carrier in 2014 and established a research group, Synthetic and Medicinal Chemistry Research Group (SMCRG), at UKZN. Over the years, he has successfully secured several national and institutional grants and has established a well-equipped Drug Discovery Laboratory at UKZN. His research work is focused on target-based drug design and synthesis, Methodology development, and development of nanomaterial-based electrochemical biosensors. Since 2014, his research group has published more than 100 peer-reviewed articles in international journals, four book chapters, and two patents. He has successfully graduated 23 postgraduate students (12 Ph.Ds. and 11 Masters) since 2014. He is one of the top researchers at UKZN and was the recipient of several awards in recognition of his achievements.
Antibiotic administration in pregnancy, SARS-COV-2, Vikut® formula, antivirals, antimicrobials, evere acute respiratory syndrome, vaccine technology, Natural Products, Tuberculosis drugs, Phage Therapy, Quorum sensing, Leptospirosis, ocular infections
For more information please visit: https://bit.ly/3Ek136l